Dianthus Therapeutics, Inc. ( DNTH) - Key Metrics
DNTH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | $2.59 | -$1.24 | -$1.25 |
| 2025Q3 | $0.01 | -$0.97 | -$0.81 | -$0.81 |
| 2025Q2 | $0.01 | -$0.88 | -$0.67 | -$0.67 |
| 2025Q1 | $0.03 | -$0.82 | -$0.77 | -$0.77 |
DNTH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 3.98 |
| 2025Q3 | ? | -10.11 |
| 2025Q2 | ? | -5.27 |
| 2025Q1 | ? | -5.50 |
DNTH
Price: $82.51
52 week price:
Earnings Per Share: -4.23 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.5 billion